Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
Yale University
M.D. Anderson Cancer Center
Incyte Corporation
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
National Cancer Institute (NCI)
University of Alabama at Birmingham
National Institutes of Health Clinical Center (CC)
Soligenix
H. Lee Moffitt Cancer Center and Research Institute
Prescient Therapeutics, Ltd.